![]() |
市场调查报告书
商品编码
2000433
宠物基因检测和祖源分析服务市场预测至2034年-按产品类型、检测类型、检体类型、技术、最终用户和地区分類的全球分析Pet Genetic Testing & Ancestry Services Market Forecasts to 2034 - Global Analysis By Product, By Test Type, By Sample Type, By Technology, By End User and By Geography |
||||||
根据 Stratistics MRC 的数据,全球宠物基因检测和血统追踪服务市场预计到 2026 年将达到 4.8 亿美元,在预测期内以 15.6% 的复合年增长率增长,到 2034 年将达到 15.2 亿美元。
宠物基因检测和溯源服务透过DNA分析,辨识宠物的品种组成、遗传特征、健康风险和祖先来源。这些服务使用唾液或血液样本,深入了解遗传疾病、行为倾向和营养需求。检测结果有助于宠物饲主和兽医就预防保健、训练和饮食计划做出明智的决策。先进的基因组技术和资料库提高了检测的准确性和个人化程度。人们对宠物健康的日益关注以及宠物「拟人化」的趋势,推动了对这些服务的需求,从而促进了积极主动、数据驱动的宠物护理管理。
人们对识别宠物品种的兴趣日益浓厚
宠物饲主,尤其是饲养混种犬的主人,越来越关注爱犬的血统、起源和独特特征。基因检测有助于了解特定犬种的行为模式、饮食需求以及潜在的健康风险。随着宠物越来越“拟人化”,饲主也更愿意投资先进的诊断和分析服务。此外,个人化宠物照护方案的日益普及也推动了犬种鑑定试剂盒的需求。社群媒体的趋势以及宠物血统鑑定结果在社群内的共用,进一步激发了消费者的兴趣,并促进了市场的扩张。
宠物饲主缺乏意识
许多宠物饲主,尤其是发展中国家的宠物主人,并不了解基因检测的益处。他们认为此类服务并非必需或属于奢侈品,这阻碍了基因检测的普及。此外,缺乏预防遗传疾病和针对特定品种宠物的健康护理知识也阻碍了市场渗透。兽医在基因检测方面的指导不足也降低了消费者的信心。这些因素共同导致市场成长放缓,尤其是在对价格敏感的新兴经济体。
与兽医医疗平台合作
基因检测数据与兽医记录相结合,可为宠物提供个人化的健康护理方案。这种整合有助于早期发现遗传疾病,从而改善预防保健和治疗效果。兽医医院和数位宠物健康平台可以利用基因资讯提供个人化的营养管理和健康计划。远端医疗和数位健康生态系统的兴起进一步促进了数据的无缝共用和分析。这些进步有望提升基因检测服务的提案,并推动其在全球的普及应用。
影响消费者信任的准确性问题
调查方法的差异和品种资料库的缺失会导致结果不一致且不可靠。品种误判和健康风险预测不准确会导致宠物饲主不满。此类不准确之处会损害品牌信誉并降低復购率。此外,缺乏标准化的法规和品质标准也增加了误导性宣传的风险。应对这些挑战对于维护消费者信任和确保市场的长期永续性至关重要。
新冠疫情对宠物基因检测和血统鑑定服务市场产生了复杂的影响。初期,供应链中断和兽医就诊限制影响了产品分销和服务供应。然而,疫情封锁期间宠物饲养量的激增显着扩大了潜在基本客群。居家时间增多的宠物饲主更重视宠物的健康状况和血统资讯。电子商务平台的兴起推动了家用DNA检测套组的销售。此外,疫情期间人们对预防性医疗保健意识的提高也促进了对基因检测服务的需求。整体而言,疫情加速了市场的数位化,并带来了长期成长机会。
在预测期内,DNA检测套组细分市场预计将占据最大的市场份额。
由于DNA检测套组盒为宠物饲主提供了便利性和易用性,预计在预测期内,该细分市场将占据最大的市场份额。这些试剂盒允许在家中采集检体,无需频繁前往兽医诊所。价格实惠且易于使用的检测套组的日益普及推动了其应用。各公司不断创新,以提供更快、更准确的检测结果。直接面向消费者(D2C)模式的日益普及也进一步促进了该细分市场的成长。此外,强大的线上分销管道也提高了产品在全球市场的可近性。
在预测期内,兽医院细分市场预计将呈现最高的复合年增长率。
在预测期内,由于兽医诊所对基因检测服务的参与度不断提高,因此兽医诊所板块预计将呈现最高的成长率。兽医诊所提供专家指导,从而提高了检测结果的准确性和可靠性。宠物饲主预防保健意识的增强推动了诊所对基因检测的需求。将基因数据整合到常规兽医护理中进一步促进了该服务的使用。诊所也提供包含基因筛检的综合健康套餐。预计这一趋势将显着加速该板块的成长。
在预测期内,北美预计将占据最大的市场份额,这主要得益于其较高的宠物拥有率和消费者较高的宠物意识。主要市场参与者的存在以及先进的兽医基础设施为该地区的成长提供了支撑。该地区的宠物饲主愿意为优质的医疗和预防保健服务付费。宠物「拟人化」趋势的日益增长也推动了对基因检测解决方案的需求。此外,成熟的电子商务和直销管道提高了产品的供应量。有利的法规环境也进一步巩固了该地区的市场主导地位。
在预测期内,亚太地区预计将呈现最高的复合年增长率,这主要得益于快速的都市化和不断增长的可支配收入。宠物拥有率的提高,尤其是在新兴经济体,正在扩大基本客群。人们对宠物健康和福祉的日益关注,推动了基因检测服务的使用。兽医基础设施和数位医疗平台的扩张也为市场成长提供了支持。此外,全球企业和本土Start-Ups的进入加剧了市场竞争。这些因素共同促成了亚太地区成为市场成长最快的地区。
According to Stratistics MRC, the Global Pet Genetic Testing & Ancestry Services Market is accounted for $0.48 billion in 2026 and is expected to reach $1.52 billion by 2034 growing at a CAGR of 15.6% during the forecast period. Pet Genetic Testing & Ancestry Services involve DNA-based analysis to identify a pet's breed composition, genetic traits, health risks, and ancestry. These services use saliva or blood samples to provide insights into inherited conditions, behavioral tendencies, and nutritional needs. Results help pet owners and veterinarians make informed decisions regarding preventive healthcare, training, and diet planning. Advanced genomic technologies and databases enhance accuracy and personalization. Growing awareness of pet health and the humanization of pets are driving demand for these services, supporting proactive and data-driven pet care management.
Rising interest in pet breed identification
Pet owners are increasingly curious about the lineage, heritage, and unique traits of their pets, particularly for mixed-breed animals. Genetic insights help in understanding behavioral patterns, dietary requirements, and potential health risks associated with specific breeds. The growing humanization of pets is encouraging owners to invest in advanced diagnostic and analytical services. Additionally, the popularity of personalized pet care solutions is boosting demand for breed identification kits. Social media trends and community sharing of pet ancestry results are further amplifying consumer interest and market expansion.
Limited awareness among pet owners
Many pet owners, especially in developing regions, are unfamiliar with the benefits of genetic testing. The perception that such services are non-essential or luxury offerings restricts widespread adoption. Lack of education regarding genetic disease prevention and breed-specific healthcare also hampers market penetration. Furthermore, limited availability of veterinary guidance on genetic testing reduces consumer confidence. These factors collectively slow down market growth, particularly in price-sensitive and emerging economies.
Integration with veterinary healthcare platforms
Genetic testing data can be combined with veterinary records to provide personalized healthcare plans for pets. This integration enables early detection of hereditary diseases, improving preventive care and treatment outcomes. Veterinary clinics and digital pet health platforms can leverage genetic insights to offer tailored nutrition and wellness programs. The rise of telemedicine and digital health ecosystems further supports seamless data sharing and analysis. Such advancements are expected to enhance the value proposition of genetic testing services and expand their adoption globally.
Accuracy issues affecting consumer trust
Variations in testing methodologies and limited breed databases can lead to inconsistent or unreliable results. Incorrect breed identification or health risk predictions may lead to dissatisfaction among pet owners. Such inaccuracies can damage brand credibility and reduce repeat purchases. Additionally, lack of standardized regulations and quality benchmarks increases the risk of misleading claims. Addressing these challenges is crucial for maintaining consumer trust and ensuring long-term market sustainability.
The COVID-19 pandemic had a mixed impact on the pet genetic testing and ancestry services market. Initially, supply chain disruptions and restrictions on veterinary visits affected product distribution and service accessibility. However, the surge in pet adoption during lockdowns significantly increased the potential customer base. Pet owners spending more time at home showed greater interest in understanding their pets' health and ancestry. The rise of e-commerce platforms facilitated the sale of home-based DNA testing kits. Additionally, growing awareness of preventive healthcare during the pandemic boosted demand for genetic testing services. Overall, the pandemic accelerated digital adoption and long-term growth opportunities in the market.
The DNA testing kits segment is expected to be the largest during the forecast period
The DNA testing kits segment is expected to account for the largest market share during the forecast period as it offers convenience and ease of use for pet owners. These kits enable sample collection at home, eliminating the need for frequent veterinary visits. Increasing availability of affordable and user-friendly testing kits is driving widespread adoption. Companies are continuously innovating to provide faster and more accurate results. The growing popularity of direct-to-consumer models is further supporting segment growth. Additionally, strong online distribution channels are enhancing product accessibility across global markets.
The veterinary clinics segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the veterinary clinics segment is predicted to witness the highest growth rate due to increasing professional involvement in genetic testing services. Veterinary clinics provide expert guidance, improving the accuracy and reliability of test results. Growing awareness of preventive healthcare among pet owners is driving demand for clinic-based testing. Integration of genetic data into routine veterinary care is further enhancing service adoption. Clinics are also offering comprehensive health packages that include genetic screening. This trend is expected to accelerate the growth of this segment significantly.
During the forecast period, the North America region is expected to hold the largest market share owing to high pet ownership rates and strong consumer awareness. The presence of leading market players and advanced veterinary infrastructure supports regional growth. Pet owners in the region are more willing to spend on premium and preventive healthcare services. The increasing trend of pet humanization is also driving demand for genetic testing solutions. Additionally, well-established e-commerce and direct-to-consumer distribution channels enhance product accessibility. Favorable regulatory frameworks further contribute to the dominance of this region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid urbanization and rising disposable incomes. Increasing pet adoption rates, particularly in emerging economies, are expanding the customer base. Growing awareness about pet health and wellness is encouraging the use of genetic testing services. The expansion of veterinary infrastructure and digital healthcare platforms supports market growth. Additionally, the entry of global players and local startups is intensifying market competition. These factors collectively position Asia Pacific as the fastest-growing region in the market.
Key players in the market
Some of the key players in Pet Genetic Testing & Ancestry Services Market include Basepaws, Inc., Embark Veterinary, Inc., Zoetis Inc., Neogen Corporation, Animal Genetics, Inc., Orivet Genetic Pet Care, DNA My Dog, Paw Print Genetics, PetGenoma, EasyDNA, IdentiGEN Ltd., Genoscoper Laboratories, Illumina, Inc., Thermo Fisher Scientific Inc. and Mapmygenome India Ltd.
In September 2024, Embark introduced a veterinarian- and geneticist-backed supplement range, marking its entry into broader pet health beyond DNA testing. This expansion positioned the company as a more holistic pet wellness provider.
In June 2022, Zoetis officially completed the acquisition of Basepaws. The deal strengthened Zoetis's portfolio by integrating Basepaws' genetic insights, enabling veterinarians and pet owners to better understand disease risks and improve early detection.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.